Changeflow GovPing Pharma & Healthcare Acute Amino Acid Response of Proprietary Beverages
Routine Notice Added Final

Acute Amino Acid Response of Proprietary Beverages

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

The National Institutes of Health registered clinical trial NCT07534020 on ClinicalTrials.gov. The trial evaluates post-meal amino acid response to four proprietary protein beverage formulations (carbonated test protein beverage, standard protein beverage, control protein beverage, and Study Product D) in generally healthy adults.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH registered a new clinical trial (NCT07534020) on ClinicalTrials.gov titled 'Acute Amino Acid Response of Proprietary Beverages.' The trial will study post-meal amino acid responses in generally healthy adults receiving one of four beverage interventions: carbonated test protein beverage, standard protein beverage, control protein beverage, and Study Product D.

Affected parties include clinical research organizations, contract research organizations conducting the trial, and manufacturers of the proprietary beverages under study. This registry entry does not create compliance obligations but establishes the formal trial parameters for investigators and sponsors to follow under applicable FDA and IRB oversight frameworks.

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Acute Amino Acid Response of Proprietary Beverages

N/A NCT07534020 Kind: NA Apr 16, 2026

Abstract

The primary objective of this study is to evaluate post-meal amino acid in response to a proprietary beverages in generally healthy adults.

Conditions: Healthy

Interventions: Study Product C: carbonated test protein beverage., Study Product A: protein beverage, Study Product B: control protein beverage., Study Product D

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07534020

Who this affects

Applies to
Healthcare providers Pharmaceutical companies
Industry sector
3114 Food & Beverage Manufacturing
Activity scope
Clinical trial registration Product research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!